That’s at least one woman in every classroom, every office, every GP waiting room.*1
The POInt.
The POInt. Until recently, POI was considered rare. New data from the 2024 ESHRE guidelines and the 2025 IMS recommendations have changed that.*² *³
POI is not rare. It is common, it is underdiagnosed, and it is undertreated, and most women living with it are managed on evidence that was never designed for them.
The average woman with POI waits years for a diagnosis, is frequently dismissed as anxious or stressed, and receives care extrapolated from research in older menopausal populations. Decades of estrogen deficiency affecting bones, heart, brain and quality of life, from a time in life when nobody is looking for it.
This is not just a patient justice issue. It is a systems failure, and at its core, a communications failure.
Not just a patient issue.
The average woman with POI waits years for a diagnosis, is frequently dismissed as anxious or stressed, and receives care extrapolated from research in older menopausal populations. Decades of estrogen deficiency affecting bones, heart, brain and quality of life, from a time in life when nobody is looking for it.
This is not just a patient justice issue. It is a systems failure, and at its core, a communications failure. The companies already selling relevant treatments are not reaching the patients who need them, because too few are being diagnosed in time.
The global POI treatment market is estimated at over
$1 billion
and growing at nearly 10% a year.*4
The evidence gap flagged in international guidelines is not only a clinical problem. It is a commercial one.
The POInt is change.
We are a catalyst organisation working at the intersection of patient experience, clinical practice and commercial interest. We bring POI into the rooms where decisions are made, in pharma, in clinical practice, in research design and in policy.
We work to ensure clinicians recognise POI earlier. We work with pharma to build the case for POI-specific research. We connect the patient voice to the people and organisations with the power to act on it.
POI is where endometriosis was a decade ago, a condition affecting millions, dismissed for years, finally gaining the recognition it deserves.
White Paper.
Click the link below to download our white-paper:
POI
in every room that matters.
That’s the POInt.
Meet our founder.
“I bring lived experience of premature ovarian insufficiency, infertility, and donor-egg IVF. This experience does not replace scientific expertise, but it has shaped how I think about communication, education and support. It has given me a clear understanding of how information is received, where gaps exist and how language can either empower or overwhelm.”
Kate Booth
Medical communications consultant, patient voice specialist in women’s health, Daisy Network advocate, and person living with POI.
For more information visit www.kommunikate.uk
